1/9
Looks like no tags are added yet.
Alkylating Agents
MoA: Cross-link DNA strands, inhibiting DNA + protein synthesis.
Cyclophosphamide and Ifosfamide
Concerns: hemorrhagic cystitis (due to acrolein)
Monitor: hematuria and dysuria
Prevention: Adequate hydration and adding Mesna with all ifosfamide doses and high cyclophosphamide doses (> 1 g/m2).
Busulfan
Concerns: pulmonary toxicity
Carmustine
Concerns: neurotoxicity (like seizures) and pulmonary toxicity
Platinum-Based Compounds
MoA: Cross-link DNA to interfere with DNA synthesis and replication.
Cisplatin
Concerns:
Hypersensitivity rxns so monitor for signs and sx of anaphylaxis.
Nephrotoxicity
Prevention: Adequate hydration, adding amifostine, and limiting dose per cycle to < 100 mg/m2.
Monitor renal function.
Ototoxicity so monitor signs and sx of hearing loss or tinnitus and perform an audiogram at baseline.
Peripheral neuropathy so monitor fos signs and sx of extremity numbness, paresthesia, and/or pain.
Oxaliplatin
Concern: Acute sensory neuropathy exacerbated by cold so avoid cold exposures and monitor for abnormal sensations in the hands, feet, throat, etc.
Anthracyclines
MoA: Inhibits topoisomerase II.
Doxorubicin (-rubi- = red body fluids )
Concern: cardiotoxicity so monitor LVEF before and after tx
Prevention: Limit total lifetime cumulative dose to 450-550 mg/m2 and admin dexraxozane when cumulative dose in > 300 mg/m2. Must stop drug once it meets threshold.
Monitor: cumulative dose = dose in mg/m2/cycle x total number of cycles
Mitoxantrone (blue discoloration)
Topoisomerase I Inhibitors
MoA: Blocks the coiling and uncoiling of the double-stranded DNA helix during the S-phase.
Irinotecan
Concerns: acute diarrhea (during or immediately after) + cholinergic sx and also, delayed diarrhea (> 24 hrs after infusion)
Prevention: atropine (anticholinergic) for acute diarrhea
Treatment: loperamide for delayed diarrhea
Topoisomerase II Inhibitors
MoA: Blocks the coiling and uncoiling of double-stranded DNA during the G2 cycle.
Etoposide
Concern: infusion rate-relation hypotension so infuse over at least 30-60 minutes.
Vinca Alkaloids
MoA: Inhibit microtubule formation during the M phase.
Vincristine
Concerns:
Peripheral neuropathy so monitor for extremity numbness, paresthesia, and pains.
Prevention: limit single dose to 2 mg
Autonomic neuropathy (e.g., constipation)
Paralysis and death if given intrathecally.
Prevention: prepare in small IV bad (like piggybacks) that canโt be use for intrathecal admin.
Taxanes
MoA: Inhibits the depolymerization of tubulin during the M phase.
Paclitaxel
Note: Use non-PVC bag + tubing and a 0.22 micron filter.
Concerns:
Peripheral neuropathy
Hypersensitivity rxns
Prevention: pre-medicare with systemic steroid, diphenhydramine, and H2RA
Docetaxel
Concern: fluid retention
Pyrimidine Analog Antimetabolites
MoA: Inhibit pyrimidine DNA synthesis during S phase.
Fluorouracil and Capecitabine
Concerns:
Hand-foot syndrome (palmar plantar erythrodysesthesia) so monitor for painful erythema and skin peeling.
Management: use lukewarm water/cold compresses, apply emollients, limit activities that increase friction and pressure to hands and feets, etc.
Diarrhea
Mucositis
Prevention: good oral hygiene, ice chips, and frequent rinsing with sodium bicarbonate or NaCl solutions
Treatment: viscous lidocaine 2% magic mouthwash and thrush treatment (nystatin oral susp or clotrimazole troches) if indicated.
DPD deficiency increases risk of severe toxicity
Treatment: use uridine triacetate within 96 hrs for overdose or early-onset toxicity
Drug interaction with warfarin (can increase INR).
Note: Leucovorin or levoleucovorin is admin with 5FU to increase efficacy.
Folate Antimetabolites
MoA: Interferes with enzyme incolved in the folic acid cycle, blocking purine and pyrimidine biosynthesis during the S phase.
Methotrexate
Concerns:
Nephrotoxicity with high doses > 500 mg/m2
Prevention: use leucovorin or levoleucovorin, hydrate with IV sodium bicarbonate to alkalinize urine, and avoid NSAIDs + salicylates.
Treatment: Glucarpidase
Gastrointestinal toxicity (e.g., diarrhea, mucositis)
*Folic acid is not effective for high dose dose.
Miscellaneous Chemo Agents
Arsenic trioxide
QT prolongation
Bleomycin
Pulmonary toxicity so limit cumulative dose to 400 units.
Hypersensitivity rxns
Bortezomib and Carfilzomib
Herpes reactivation (zoster and simplex) so tx with acyclovir or valacyclovir.
Lenalidomide, Pomalidomide, and Thalidomide
Severe birth defects so at baseline, it requires 2 (-) tests before starting treatment.
Thrombosis (DVT/PE)
Pegaspargase
Hypersensitivity rxns